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EDITORIAL
Developing a new electrophysiology 
service and training platform - 
narrowing the gap
mended as the standard of care in many circumstances.(7,8) 
Device therapy has also evolved from pacing for bradycardias 
to more sophisticated device therapies such as improving heart 
failure and the prevention of arrhythmic death.(9,10) Up until 
2019, there was only one full-time specialist electrophysiology 
(EP) service in the state health care sector, situated at Groote 
Schuur hospital in Cape Town, which bore the brunt of invasive 
arrhythmia management for the state sector of the Western 
Cape Province.
The reasons for this lack of specialist EP services in the state 
sector are likely to be multifactorial. There are a limited number 
of consultant cardiology posts available, and until recently, no 
local training opportunities, with reliance on 2-year training 
fellowships abroad. Prof Doubell, Head of Division, Cardiology, 
Department of Medicine at Stellenbosch University, realised 
that these obstacles could only be overcome by expanding the 
EP service in the state sector, thereby expanding the local 
training platform and reducing the dependency on EP training 
programmes abroad. The formation of SUNHEART (a centre 
of the Division of Cardiology, Department of Medicine, 
Stellenbosch University) provided a platform for collaboration 
with important role players from industry to establish what has 
become the “SUNHEART Electrophysiology program,” and 
was fundamental in achieving this vision.
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South Africa has a population of more than 58 million 
people,(1,2) of which only 9.4 million have private health 
insurance, and 71.5% would preferentially visit a public sector 
primary healthcare clinic as their first point of contact when 
seeking medical assistance.(3) In addition, non-communicable 
diseases, including cardiovascular disease, are on the rise in 
South Africa and currently form a significant portion of the 
burden of disease in our population.(4,5) Arrhythmias make up 
a significant portion of cardiac consultations (in the range of 
40%),(6) and arrhythmia management has changed significantly 
over time to a point where catheter ablation is being recom-
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FIGURE 1: Outline of the components of the SUNHEART Electrophysiology programme.
EP = Electrophysiology. Orange block: the starting point, an existing cardiac catheterisation laboratory. Grey block: the goal, an EP service 
delivery and training platform. Yellow block: the 3 key gaps that needed to be filled. 
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FIGURE 2: ECGs from the index case. A: Pre-excited atrial fibrillation. B: Post cardioversion. C: Post ablation
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Prof Chin at Groote Schuur hospital, and in the private sector 
(Dr Razeen Gopal, Panorama Mediclinic and Dr Faizel Lorgat, 
Christian Barnard Memorial Hospital). This was rounded off 
by a fellowship at the Oxford Heart Centre.
In parallel to the concomitant training of an electrophysiologist 
and EP technologist, was the important process of upgrading 
one of our existing cardiac catheterisation laboratories with 
the necessary equipment to perform invasive EP procedures. 
Again, industry was instrumental in ensuring that Tygerberg 
Hospital had full access to state-of-the-art technology.
The SUNHEART EP programme was launched in January 2019, 
the index case being a patient who had presented with pre-
excited atrial fibrillation, and there was much excitement when 
we were able to successfully ablate the accessory pathway 
(Figures 2, 3 and 4). Since then, we have done 75 invasive EP 
cases (24 typical atrial flutter ablations, 19 accessory pathways, 
13 slow pathway modifications, 12 diagnostic EP studies, 4 atrial 
tachycardias/atypical atrial flutters, one ventricular tachycardia 
and 2 AV node ablations). In addition to this, we have implanted 
In 2015, we began the groundwork for the programme based 
on the 5 pillars illustrated in Figure 1. The starting point was 
an existing cardiac catheterisation laboratory, with the aim of 
achieving an EP service delivery and training platform. The 
means to achieving that goal were to train an electrophysiol-
ogist and a cardiac technologist, and to fully equip the 
catheterisation laboratory. In 2016, the SUNHEART EP fellow-
ship began by way of an institutional collaboration with several 
centres, funded by industry partners. Prof Ashley Chin’s EP 
programme at Groote Schuur Hospital formed the core of the 
local training, supplemented by training time in the private 
sector (Dr Razeen Gopal at Panorama Mediclinic). A further 9 
months of training abroad (a 3-month complex device 
fellowship at the Charité University Hospital in Berlin, and a 
6-month invasive EP fellowship at the Oxford Heart Centre, 
John Radcliffe Hospital in Oxford) ensured a comprehensive 
training programme leading to success in the European Heart 
Rhythm Association exams in device therapy and invasive EP. 
An important part of this training programme was a parallel 
training programme for a cardiac technologist, who was 
afforded local training fellowships in the state sector with 
COVID-19 AND CARDIOVASCULAR DISEASE
FIGURE 3: From left to right: Mr Kumeshin Moodley (cardiac technologist) and Dr Jane Moses (electrophysiologist) during the case.
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our first leadless pacemaker and our first subcutaneous 
implantable cardioverter-defibrillator. We have also established 
dedicated arrhythmia and complex device outpatient clinics. 
While we take pride in what we have achieved thus far, there 
is still much that needs to be done, particularly in establishing a 
comprehensive training programme. This reflection has allowed 
us to share the success we have had in establishing this new 
EP programme. What we have learned thus far can be sum-
marised as follows:
 ■ There is a great need for specialist electrophysiology 
services.
 ■ The obstacles we face in a resource-limited society (lack of 
posts, reliance on training abroad) can be overcome.
 ■ Collaboration between stakeholders (public sector, private 
sector, industry, not for profit organisations) is key to 
achieving success.
 ■ The infrastructure needs to be developed in parallel with 
the personnel.
 ■ Support from colleagues (cardiologists, anaesthetists, 
cardiothoracic surgeons) is paramount for a comprehensive 
service.
To sustain this success of improving patient’s access to specialist 
arrhythmia management, it will only be possible if we establish 
a training platform to produce the electrophysiologists and EP 
technologists required.
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FIGURE 4: From left to right: Mr Kumeshin Moodley (cardiac 
technologist), Dr Jane Moses (electrophysiologist), Prof Anton 
Doubell (Head of Division) after the fi rst case.
